George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Bloomberg full of its usual BS.
Pfizer carry 81% of all sales in the USA and sold Zanatc Over the counter and removed labeling an warnings .
Sanofi or GSK Boehringer did none on this Corrupt USA Pharma practice.
No cases filed against GSK or Sanofi.
Its a case of pfizer going to carry full liability for there OTC sales
No, Pfizer had the biggest market shae at 81% and flouted FDA Rules, GSK only produced in the UK as prescription Ranitidine and Sanofi the same as BI did.
Pfizer selling OTC and removing labeling, as effectively left them with 81% liability
Graywolf, it as nothing to do with HLN, its a prescription medication that was discontinued some time back.
Zanatac = Ranitidine was prescription, not OTC, and when Pfizer sold OTC they became liable due to removing labeling
Pfizer Hit With Class Action Suit Over OTC Zantac Labeling
A group of consumers filed a class action suit against Pfizer, alleging that the company knew or should have known that its over-the-counter heartburn drug Zantac (ranitidine) was contaminated with dangerous levels of NDMA and unsafe for consumption.
The complaint alleges that Pfizer marketed its OTC Zantac as safe and effective despite “evidence to the contrary,” noting that the drug’s original labeling did not list NDMA or disclose the contaminant’s properties as a probable carcinogen.
“NDMA would not be present if the medication were properly synthesized,” according to the complaint. The medications “expose users to NDMA well above the legal limit,” so they are “not fit for human consumption.”
Pfizer was the original NDA holder for OCT Zantac, manufacturing and controlling the drug from 2000 to 2006. The company and other prominent drugmakers, including the drug’s current brand name manufacturer, Sanofi, have recalled their ranitidine products. Pharmacy chains such as Walgreens, Rite Aid and CVS, have also followed suit.
Pfizer Hit With Class Action Suit Over OTC Zantac Labeling.A group of consumers filed a class action suit against Pfizer, alleging that the company knew or should have known that its over-the-counter heartburn drug Zantac (ranitidine) was contaminated with dangerous levels of NDMA and unsafe for consumption.
The complaint alleges that Pfizer marketed its OTC Zantac as safe and effective despite “evidence to the contrary,” noting that the drug’s original labeling did not list NDMA or disclose the contaminant’s properties as a probable carcinogen.
“NDMA would not be present if the medication were properly synthesized,” according to the complaint. The medications “expose users to NDMA well above the legal limit,” so they are “not fit for human consumption.”
Pfizer was the original NDA holder for OCT Zantac, manufacturing and controlling the drug from 2000 to 2006. The company and other prominent drugmakers, including the drug’s current brand name manufacturer, Sanofi, have recalled their ranitidine products. Pharmacy chains such as Walgreens, Rite Aid and CVS, have also followed suit.
utter rubbish.
The Atlantic council are paid by the Kurdistan Democratic Party and have many people who benefit directly from illegal oil sales.
Looking tat this company.s history, it appears it's shares are worth around 2.3 pence, when looking at historic events where Kurdistan/American/UK/Israeli/UAE interests took $ billions.
I am not invested, but would expect people to have some form of intelligence to invest, and its notable looking through the history of this board, many KDP /PUK Affiliated people are posting on this Kurdistan oil situation
The Washington Institute for Near East Policy. Like all USA , UK quangos try to get a stronger foothold in Iraq via Kurdistan.
The piece I read in France 24 is another attempt by the Likes of Knight at Washington to get the USA hands on Iraq Oil, especially as Russia oil is not in the market.
The people who write these one sided articles would do well to remember, they failed with ISIL and have Iran and Russia to thank that Kurdistan is still a region, due the Iraq, Russia, the PKK saving Kurdistan...
Kurdistan is a region of Iraq, it as no rights to control oil policy, that would be like Georgia controlling USA oil policy, if the Washington Near East institute had its way
https://www.france24.com/en/live-news/20220718-oil-dispute-sharpens-baghdad-kurd-tensions-amid-deadlock
Complete fabrication of facts.
Iraq Supreme court is no quango and as Jurisdiction,
Iraq Kurdistan is a region of Iraq.
Proven over many court cases.
Did a UAE company argue in a UK Court of intentional arbitration that Kurdistan failed to pay for oil and gas, and the international court stated Kurdistan was under Iraq Law.
Not invested here, and only took note due to Zahawi games.
American law firms, the ones the KDP pay and lobby the US Government, but USA Policy and international law is Iraq Supreme court as full jurisdiction its why major oil service providers pulled out and continue to do so. I read details on here and it covers 100's of Kurdistan issues.
Best of luck
https://ekurd.net/nadhim-zahawi-sprinting-top-uk-2022-07-11
Lots pf waffle from Toff.
Feverdrinks as a brand and products that is wanted year round.
Low price could encourage predators like Diageo to attempt to buy or Nestle .
Expect rebound , as the company is robust and will sort its US labour shortage
HKN Energy who hold an oil contract cannot sell it, its an illegal contract an many others are illegal.
According the Iraq Supreme court Gulf Keystone oil contract is also illegal .
https://abcnews.go.com/International/wireStory/oil-minister-iraq-act-annul-kurdish-oil-deals-86382437
Appears the Nahidam Zahawi files are full of illegal oil contracts for all companys in Iraq Kurdistan
Gulf Keystone is one of many Zahawi was involved with . Dose it explain the share price crash ? Iraq taking control and throwing out companys?
https://ekurd.net/nadhim-zahawi-sprinting-top-uk-2022-07-11
Jet2 just lost £488 million, and its Capex is only £1.5 billion.
It over expanded started running flights from ares like Bristol where they are often cancelled , leaving customers fuming and angry, which means no repeat business.
On top, they have just promised every employees a £1000 bonus payment at the end of September, and that is on top of a 8% pay rise.
Its bad enough the UK chancellor was paying JET2 wages for 18 months, now the company is losing £1.7 million a day and giving shareholder money away.
Another Monarch Thomas Cook insight here
Dunnie
Vir carrying a cash balance at present of $1 billion .
Keep your eyes on ARCT... There results will be deficit again, but the low dose freeze dried vaccine of 5 ug could cause a big stir, its already improved Biontech Pfizer vaccine. When given as a booster its 54 fold better than Biontech Pfizer booster on people who have had 2 doses of Biontech Pfizer
Nasdaq ARCT.
Trial 3 in Vietnam is due this month -all under rolling submission- Vin Group (VinBiotech) brought technology from ARCT in August and ARCT supply all nanolipid particles an all raw materials. Vietnam as 200 million people.
Also in trial as booster to Pfizer Biontech in Singapore USA Indonesia - its been trialed in 7 other countries as a booster to Astra Vaccine that been given to people, already . https://ir.arcturusrx.com/static-files/198c6d28-bb6b-4162-a7a6-5854a0fd2d6c
I doubt very much it will used that much as a booster. Pfizer contracts with most countries are through till 2023.
It will be used more in low income middle income country's where GSK will roll it out with Sanofi at a pace no other vaccine maker as.
Booster for existing vaccine like mRNA could come from Arcturus Therapeutics ...
New data from the Phase 1/2 booster trial, sponsored by Arcturus and currently ongoing in U.S. and Singapore, demonstrated that ARCT-154 and ARCT-165, when administered in low doses (5 mcg) at least five months following initial vaccination with Comirnaty®, yielded robust increases of 54- and 47-fold, respectively, in neutralizing antibody responses against the Omicron variant. These findings provide additional data to recently updated results from the Phase 1/2 demonstrating robust neutralizing antibody responses against SARS-CoV-2 D614G strain as well as several variants of concern, and is expected to support the expansion of clinical development of the candidates to evaluate their potential as booster vaccines.
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
https://www.globenewswire.com/news-release/2022/02/23/2390095/0/en/Sanofi-and-GSK-to-seek-regulatory-authorization-for-COVID-19-vaccine.html
Dunnieboy. SA article, where it fails is with keys issues like Reuters fail . Sotrovimab IM Version as been waiting at the FDA for some time now, and you see the likes of Lilly claim there new mAb works on Omicron, with no data, yet Sotrovimab IM with all its data is sitting waiting still and its IV form as been approved for 10 months now and is the same.
I would expect VIR to push ahead with the vaccine they are working towards . One key issue is that Reuters are run by Pfizer on Covid look at Reuters reporting hub on Covid it as Pfizer Board running it - and its pushing Lilly mAbs , they see VIR GSK as the biggest threat to them with a vaccine development on the board to come within 18 months
denby69.
Reuters reporting is biased and its wrong, Astra monoclonal antibody failed on all variants of Omicron. . As for coulmbia professor or whoever, these reports are times to come out by Lilly $ behind them. VIR were aware of this Columbia report and veesler labs produced all data on Sotrovimab in advance of it .